+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Osteoarthritis Treatment Market - Growth, Trends, and Forecast (2019 - 2024)

  • ID: 4756814
  • Report
  • 120 pages
  • Mordor Intelligence
UP TO OFF
until Dec 31st 2019
1 of 5

FEATURED COMPANIES

  • Bayer Healthcare
  • Iroko Pharmaceuticals
  • Lifecore Biomedical LLC
  • Merck Serono
  • Sanofi SA
  • Smith & Nephew PLC
  • MORE
Market Overview

The growth of the global osteoarthritis treatment market is due to the rising geriatric population, increasing incidence of osteoarthritis disorders, and rising demand for minimally invasive surgical procedures.

The global increase in geriatric population leads to higher incidence of osteoarthritis (OA) among the aged population. It is the most common type of joint disease, found in people aged more than 65 years, which is accompanied by mortality and decreased quality of life. Osteoarthritis (OA) is one of the most common causes of pain and disability in the elderly population and is driving the growth of the market.

There has also been a rising demand for minimally invasive surgical procedures to treat osteoarthritis, worldwide. MAKOplasty is a minimally invasive knee surgery that relieves the pain caused by osteoarthritis. However, there are also various minimally invasive surgeries that have been reported and are being used nowadays, as they cause less pain and incisions.

In addition, there are many osteoarthritis research studies ongoing on cartilage, the lubricating surface in the joint. The work is being done to re-grow the cartilage using stem cells treated with molecules to aid their growth. Hence, ongoing research and rising government support help in creating new opportunities for the growth of the osteoarthritis treatment market.

Scope of the Report

As per the scope of the report, osteoarthritis, also known as degenerative arthritis, is the most commonly occurring chronic condition that affects the joints. This leads to severe joint pain and stiffness of the affected body parts. Osteoarthritis can be treated by several treatments, which include exercise for reducing joint pain, and pain medications. Pain medication includes drugs, such as paracetamol, naproxen, and ibuprofen. Presently, there is no cure for osteoarthritis, but the treatment is aimed at managing the symptoms.

Key Market Trends

Non-steroidal Anti-inflammatory Drugs (NSAIDs) is the Largest Segment Under Drugs that is Expected to Grow During the Forecast Period

The NSAIDs market is expected to grow during the forecast period, as they are found to be the most commonly used drugs to ease pain, inflammation, and stiffness that come with arthritis, bursitis, and tendinitis. Thus, NSAIDs have been an important treatment for the symptoms of osteoarthritis for a very long time. They are also cheap and often among the first medicines prescribed for people with achy joints.

The hyaluronic acid injections are also used as a treatment option, when a patient is no longer able to control osteoarthritis pain with ibuprofen or other non-steroidal anti-inflammatory drugs (NSAIDs).

North America has been reported with the Fastest and the Largest Growth and is Expected to follow the Same Trend over the Forecast Period

The North American market is expected to grow, owing to the increasing lifestyle changes, an increasing number of obesity cases, and an extensive rise in the geriatric population in North America. As a result, the adoption of treatment and drugs is also increasing in the region. The availability of better treatment options, high awareness among people, government reimbursement policies, and the willingness to take up treatment are expected to add up to the growth of the osteoarthritis treatment market in the region.

Competitive Landscape

Various manufacturers are expanding, owing to new product launches in the market. These manufacturers have also seen positive developments in the United States, Europe, Latin America, and Asia. There are also strict regulatory policies, which have resulted in a reduction of investments made by the drug companies in the R&D of new products.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bayer Healthcare
  • Iroko Pharmaceuticals
  • Lifecore Biomedical LLC
  • Merck Serono
  • Sanofi SA
  • Smith & Nephew PLC
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Geriatric Population
4.2.2 Increasing Incidence of Orthopedic Disorders
4.2.3 Rising Demand for Minimally Invasive Surgical Procedures
4.3 Market Restraints
4.3.1 High Cost Associated with Hyaluronic Acid Products
4.3.2 High Side Effects and Lack of Safety of Products
4.4 Porter' s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Drugs
5.1.1 By Food Supplements
5.1.1.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs)
5.1.1.2 Corticosteroids
5.1.1.3 Hyaluronic Acid Injection
5.1.1.3.1 Single Injections
5.1.1.3.2 Multiple Injections
5.1.1.4 Other Drugs
5.1.2 By Anatomy
5.1.2.1 Ankle Osteoarthritis
5.1.2.2 Hip Osteoarthritis
5.1.2.3 Knee Osteoarthritis
5.1.2.4 Shoulder Osteoarthritis
5.1.2.5 Other Anatomies
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer Healthcare
6.1.2 Lifecore Biomedical LLC
6.1.3 Merck Serono
6.1.4 Pfizer Consumer Healthcare
6.1.5 Iroko Pharmaceuticals
6.1.6 Sanofi SA
6.1.7 Smith & Nephew PLC
6.1.8 Zimmer Biomet

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Bayer Healthcare
  • Lifecore Biomedical LLC
  • Merck Serono
  • Pfizer Consumer Healthcare
  • Iroko Pharmaceuticals
  • Sanofi SA
  • Smith & Nephew PLC
  • Zimmer Biomet
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll